OraQuick(R) Advance(TM) to Be Featured as Part of D.C Health Department's City-Wide HIV Testing Campaign Launch on June 27, 200
26 Giugno 2006 - 12:22AM
Business Wire
OraSure Technologies, Inc. (NASDAQ: OSUR): -0- *T WHAT: OraSure
Technologies, Inc. (NASDAQ: OSUR) will take part in the official
launch of the D.C. Health Department's city-wide HIV testing
campaign on June 27, National HIV Testing Day (NHTD). The citywide
campaign will encourage all District residents to learn their HIV
status. The D.C. Health Department plans on distributing tests
through a variety of settings including hospital emergency rooms,
private physicians' offices, community health programs and public
health settings. OraSure's OraQuick(R) ADVANCE(TM) Rapid HIV-1/2
Antibody Test is the first and only U.S. FDA approved oral fluid
rapid HIV test that can detect antibodies to both HIV-1 and HIV-2
in 20 minutes The test can be used not only with oral fluid, but
also with finger-stick or venipuncture whole blood or plasma
specimens - offering ease of use and accessibility in a variety of
settings. In observance of NHTD, OraSure's CEO and President Doug
Michels will address the importance of HIV testing and prevention
at a press conference hosted by the National Association of People
With AIDS (NAPWA) on Monday, June 26. The Company will also join
with NAPWA and POZ Magazine to Open the NASDAQ Stock Market on
NHTD, as part of OraSure and NAPWA's Mayor's Campaign Against
HIV(TM). *T WHEN/WHERE -- National Association of People With AIDS
Press Conference: June 26th, 9-11 AM, National Press Club's First
Amendment Room, Washington DC -- District of Columbia HIV Testing
Campaign Launch Event - June 27th, 10 AM, Freedom Plaza, Washington
DC -- NASDAQ Opening Bell Ceremony - June 27th, 9 AM, at NASDAQ's
MarketSite, New York City INTERVIEWS AVAILABLE
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni OraSure Technologies (NASDAQ:OSUR)
Storico
Da Lug 2023 a Lug 2024